(SMMD) Russell 2500 - Overview
Etf: Small-Cap Stocks, Mid-Cap Stocks, USA Equity, Diversified
Dividends
| Dividend Yield | 1.37% |
| Yield on Cost 5y | 1.62% |
| Yield CAGR 5y | 6.55% |
| Payout Consistency | 94.9% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 18.0% |
| Relative Tail Risk | -2.24% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.60 |
| Alpha | -0.07 |
| Character TTM | |
|---|---|
| Beta | 1.027 |
| Beta Downside | 1.010 |
| Drawdowns 3y | |
|---|---|
| Max DD | 25.50% |
| CAGR/Max DD | 0.53 |
Description: SMMD Russell 2500 January 16, 2026
The iShares Russell 2500 ETF (BATS: SMMD) seeks to track the FTSE Russell 2500 Index, allocating at least 80 % of its assets to the index’s constituent equities and permitting up to 20 % in derivatives, cash, or cash equivalents to manage liquidity and tracking error.
Key quantitative details (as of Q4 2025) include an expense ratio of 0.15 %, total assets under management of roughly $6.2 billion, and an average market-cap of about $7 billion, placing the fund squarely in the small- to mid-cap “blend” space. The index’s sector composition is dominated by technology (≈ 22 %), health care (≈ 15 %), and industrials (≈ 14 %).
Performance drivers for SMMD are closely tied to the broader U.S. economic cycle: GDP growth and consumer spending tend to lift small-cap earnings, while the Federal Reserve’s policy stance influences valuation multiples. A rising interest-rate environment typically compresses small-cap price-to-earnings ratios, whereas a dovish stance can boost them.
For a deeper, data-rich view of SMMD’s risk-adjusted returns and factor exposures, you might explore the analytics on ValueRay.
What is the price of SMMD shares?
Over the past week, the price has changed by +2.79%, over one month by +3.50%, over three months by +11.88% and over the past year by +16.10%.
Is SMMD a buy, sell or hold?
What are the forecasts/targets for the SMMD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 89.3 | 10.2% |
SMMD Fundamental Data Overview February 03, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 2.24b USD (2.24b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 2.24b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 2.24b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.70% (E(2.24b)/V(2.24b) * Re(9.70%) + (debt-free company))
Discount Rate = 9.70% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)